Unlocking Answers to Your Health

Sema4 is a health information company dedicated to improving the diagnosis, treatment, and prevention of disease through deep data analysis

Our Story

Trust in Sema4

  • Our Story

    Backed by the reputation of Mount Sinai and groundbreaking research from the Icahn School of Medicine Learn More
  • Our Technology

    Six genomic technologies used in parallel to ensure comprehensive and highly accurate screening for genetic conditions Learn More
  • Our Products

    Genetic tests to empower patients and their doctors to make better health decisions, now and in the future Learn More
  • Our Research

    Breakthrough discoveries from our scientists in the fields of genetics and genomics Learn More


    SEMA4 PRESS RELEASE | 08.21.18

    Sema4 Applies Data-Driven Approach to Develop and Launch New NIPT and Expanded Carrier Screen Tests

    “Sema4 today announced the launch of two reproductive health tests: the new Sema4 Noninvasive Prenatal Select and an enhanced version of its Expanded Carrier Screen. These products, developed with an informatics-driven approach using Sema4’s Health Intelligence Platform (SHIP), add to the company’s industry-leading portfolio of tests designed to support providers and patients from preconception to pediatrics…”